[Current status of Alzheimer's disease immunotherapy and pharmacologic effect of BAN2401.].
Araki
Shin
S
s2-araki@hhc.eisai.co.jp
D000544:Alzheimer Disease / Q000378:metabolism / Q000628:therapy*; D023582:Alzheimer Vaccines; D016229:Amyloid beta-Peptides / Q000235:genetics / Q000276:immunology* / Q000378:metabolism; D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D015195:Drug Design; D006801:Humans; D007167:Immunotherapy; D051379:Mice; D009154:Mutation
C437846:AN-1792; D023582:Alzheimer Vaccines; D016229:Amyloid beta-Peptides; D000911:Antibodies, Monoclonal